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Available online 11 June 2007AbstractAims: We evaluated the effect of modified Davidson’s fixative (mDF) on the number of lymph nodes examined and staging in patients with
colon carcinoma.
Methods: The results of two different fixation methods used in the pathological preparation of the resection specimens were analyzed.
A traditional formalin preparation with manual dissection of all nodes was performed in 117 colon specimens between January 2003
and July 2004. After July 2004, the resected specimens of 125 patients was fixated in mDF. Differences in the retrieval and number of
nodes and size of suspected nodal metastases were measured. All lymph nodes were stained with conventional H&E methods.
Results: The median number of examined nodes increased from 5 (0e17) to 13 (0e35) nodes after the introduction of mDF ( p< 0.001).
The type of resection and the T-stage influenced the number of retrieved nodes significantly. The percentage of node-positive cases in-
creased from 30% to 41% ( p¼ 0.077) with mDF, the median size of the retrieved lymph nodes decreased from 9 mm before to 6 mm after
mDF ( p< 0.001) and more micrometastases were found (6% vs. 16%, p¼ 0.03).
Conclusions: With mDF technique more lymph nodes were retrieved in the resected colon specimens. Smaller nodes and more microme-
tastases were found, leading to more node positive patients.
 2007 Elsevier Ltd. All rights reserved.
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The primary treatment for colon cancer is a radical sur-
gical resection of the affected colon segment en bloc with
removal of related mesenteric lymph nodes. Adequate
nodal staging is important for additional oncological treat-
ment and to predict long-term survival based on the TNM
classification.1 In the assessment of nodal status the number
of examined nodes is crucial. The impact of the surgeon
and the surgical technique itself on quality and survival
in patients with colorectal cancer has been described exten-
sively.2,3 However, the number of nodes detected in* Corresponding author. Department of Surgery, Martini Hospital,
PO Box 30033, 9700 RM, Groningen, The Netherlands. Tel.: þ31
505245245; fax: þ31 505245822.
E-mail address: w.kelder@mzh.nl (W. Kelder).
0748-7983/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ejso.2007.04.012a surgical specimen also depends on the diligence of the
pathologist and the extent of the pathological examina-
tion.4e13 Numerous attempts have been made to estimate
the minimal number of examined nodes for correct staging,
varying from 6 to 18.4,8,13e15
Several methods have been developed to increase lymph
node yield, including xylene fat clearance, alcohol treat-
ment and ether-based clearance. Most of these methods
require special equipment and the use of noxious volatile
compounds and are time-consuming with a delay in out-
come (up to 3 weeks).5,6,11,16e20 Modified Davidson’s fluid
(mDF) is an acetic acidealcoholeformalin-based fixative
that has been widely used for the preservation of different
tissues for histological evaluation (www.histosearch.com,
histonet archives, Davidson’s fixative).21,22 It is a rapid,
simple to use substance that provides no additional safety
hazards or disposal problems compared to routine formalin
526 W. Kelder et al. / EJSO 34 (2008) 525e530solutions. (http://members.aol.com/RSRICHMOND/histo
logy.html).
This report compares traditional neutral buffered forma-
lin fixation and manual identification of lymph nodes with
the use of mDF on number, size, and presence of metastases
of detected lymph nodes in surgical resection specimens of
colon cancer in a routine daily practice.
Patients and methodsPatientsFigure 1. Lymph nodes in the mesenteric fat turn white after mDF fixation
(arrows).All patients were treated in a Dutch teaching hospital
between January 2003 and January 2006. Patients with
evidence of distant metastatic disease were excluded from
the study as the presence of distant metastases might have
led to an unusual surgical and pathological approach that
differed from standard recommendations. Patients with
adenomas or polyps were excluded for the same reason.
Since the number of detected lymph nodes is influenced
by pre-operative radiotherapy which is routinely applied
in rectal cancer in the Netherlands, patients with rectal can-
cer were excluded from the study. Rectal cancer was defined
as a tumor situated within 15 cm from the anal verge located
beneath the peritoneal reflection. Patients with previous co-
lorectal surgery were also excluded from the study.
All patients underwent a potential radical surgical resec-
tion according to the standard rules, based on the location of
the primary tumor. The performed procedure was deduced
retrospectively from the surgical and pathological reports.PathologyAll five pathologists employed at the Martini Hospital
routinely examined the resected specimens. From January
2003 to July 2004, all 117 specimens were examined using
the traditional technique of manual dissection after over-
night fixation in 10% neutral buffered formalin. From
July 2004, after overnight fixation of the 125 specimens
in 10% neutral buffered formalin, the pericolic fat and mes-
entery was removed and immersed in mDF containing
500 ml of 37% formalin, 750 ml of absolute ethanol,
25 ml of 1.2% glacial acetic acid and 750 ml of tap water.
After mDF fixation, lymph nodes turn white in the mesen-
teric fat (Fig. 1). During the whole study period, lymph
nodes were examined with conventional H&E staining at
5 mm intervals. The size of the lymph nodes and nodal me-
tastases of node-positive patients was determined by one of
the pathologists (A.T.) retrospectively by measuring, in
millimeters, the largest diameter of the lymph node tissue
on H&E stained cross-sections of the lymph nodes.
Equivalent to the description of nodal metastases in
breast cancer, lymph node metastases <0.2 mm were called
isolated tumor cells, metastases between 0.2 and 2 mm
were called micrometastases, and metastases >2 mm
were called macrometastases.1Statistical methodsSPSS 12.01 for Windows (SPSS, Inc, Chicago, IL) was
the statistical software used for all the analyses. The level
of significance was set to 0.05 for all tests. The c2 test
was applied to test differences in proportions between
groups. The ManneWhitney U test was used to calculate
the significance of differences in continuous variables.
Factors considered to be possible determinants of the
number of examined lymph nodes and lymph node status
were first checked with an ANOVA analysis or regression
analysis depending on the type of variable. The influence of
possible determinants was also tested in multiple stepwise
regression analysis for continuous variables and binary logis-
tic regression analysis for nominal variables.
ResultsPatientsCharacteristics of the included patients and techniques
before and after the introduction of mDF are listed in Table 1.
Both groups did not differ significantlywith respect to patient
gender, age,T-stage, typeof resection, lengthof specimenand
thepathologistwhoexaminedthespecimen.Duetochangesin
the surgical staff, there was a difference in the operating sur-
geons before and after the introduction of the mDF fixation.Number of examined lymph nodesAll results for the number of examined nodes are shown
in Table 2. The median number of examined nodes for the
whole group was 10 (0e35). With traditional formalin fix-
ation the median number of nodes was 5 (0e17). After the
introduction of mDF the median number of nodes increased
significantly to 13 (0e35). The ANOVA test showed that
T-stage, the type of resection and the operating surgeon
also might have an effect on the number of nodes. No effect
was found for the pathologist and the length of the speci-
men. Linear stepwise regression analysis showed that the
Table 1






Gender ratio (_/\) 137/105 64/53 73/52 NS
Mean age 73(35e95) 74(42e91) 72(35e95) NS
T-stage NS
Tis 4 2 2
T1 13 7 6
T2 34 16 18
T3 167 84 83














Left hemicolectomy 25 8 17
Transversectomy 8 4 4
Sigmo€ıdectomy 86 46 40
Ileocecal resection 4 3 1
Surgeon p¼ 0.01
1 30 18 12
2 13 5 8
3 20 9 11
4 22 8 14
5 73 44 29
6 30 9 21
7 30 18 12











1 23 12 11
2 80 35 45
3 34 19 15
4 29 14 15
5 76 37 39
NS¼ not significant.
Table 2
Determinants of number of nodes and nodal status
Univariate (p) Multivariate (p)
Number of nodes ANOVA Linear regression
Fixation technique 0.000 0.000
T-stage 0.022 NS
Type of resection 0.042 0.010
Surgeon 0.034 NS
Pathologist NS
Length of specimen NS
Nodal status c2 Logistic regression (p)
Fixation technique 0.077 NS
T-stage 0.009 0.004
Type of resection NS
Surgeon NS
Pathologist NS
Number of nodes NS
Length of specimen NS (ANOVA)
NS¼ not significant.
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number of examined nodes, followed by the type of resec-
tion, T-stage and the operating surgeon. In this multivariate
analysis the effect of the operating surgeon and T-stage was
not significant. There was no significant difference in the
mean number of nodes per surgeon when corrected for
the type of resection. More nodes were removed with a right
or left hemicolectomy compared to the other types of resec-
tion. In patients with a T1 tumor less nodes were removed
compared to the other T-stages (mean 5 vs. mean 10).Table 3
N-stage before and after introduction of mDFN-stage
Stage Total Traditional technique mDF
N0 156 82 74
Nþa 86 35 51
N1 64 26 38
N2 21 9 13
Total 242 117 125
a All node-positive cases.Table 2 shows the results of the statistical analysis for
nodal status. Table 3 shows the N-stage before and after
the introduction of mDF. The percentage of node-positive
cases increases from 30% to 41% after the use of mDF.
The mean number of nodes was 9.9 in the node-negative
group and 10.4 in the node-positive group. The c2 testshowed a possible effect of T-stage and fixation technique
on N-stage. The type of resection, the operating surgeon,
the pathologist, the length of the resected specimen
removed and the number of examined nodes showed no ef-
fect. Both T-stage and fixation techniques were tested in
a binary logistic regression analysis. T-stage reached signif-
icance, while the fixation technique did not.
Using the cutoff point of the required 12 examined
nodes according to the Dutch Cancer Guidelines; the pro-
portion of node positive patients was 34% if less than 12
nodes were examined vs. 38% if 12 or more nodes were ex-
amined which is not significant. To determine the minimum
number of nodes to be examined for an accurate prediction
of the N-stage, we divided the patients in groups based on
the number of nodes removed. However, no difference was
noted in N-stage per group (Table 4).Number of positive nodes and size of metastasesBefore the introduction of mDF the total number of pos-
itive nodes was 84 with five micrometastases (5.9%) and 79
macrometastases (94%). After mDF fixation there were 126
positive nodes with two isolated tumor cells (1.6%), 18 mi-
crometastases (14.2%) and 106 macrometastases (84%).
This difference in the percentage of micro- and macrometa-
stases is significant ( p¼ 0.03). The median size of the pos-
itive nodes found before introduction of the fixation
Table 4
Percentage of Nþ patients per no. of nodes









528 W. Kelder et al. / EJSO 34 (2008) 525e530technique was 9 mm. After changing the technique the size
decreased to 6 mm. This difference is significant
( p< 0.001). The size of the negative lymph nodes found
in the specimens with positive lymph nodes also decreased
significantly from a median of 6 mm before the change of
technique to 4 mm after ( p< 0.001).
DiscussionMethodsThe serial study setup is not ideal for comparing two fix-
ationmethods. However, both study groupswere comparable
with respect to patient gender, age, T-stage, type of resection,
length of specimen and the pathologist who examined the
specimen. Although there was a difference in operating sur-
geons before and after the introduction of the mDF fixation,
it was not a significant factor in the multivariate analysis in
relation to the number of examined nodes. Moreover, there
was no significant difference in the mean number of nodes
per surgeon when corrected for the type of resection. There-
fore, the study setup is applicable in this particular situation.Number of examined lymph nodesThe principle of radical surgical resection of colon can-
cer includes removal of the affected colon segment with
adequate margins en bloc with all draining lymph nodes
in the corresponding mesocolon. The 5-year survival rate
is 70e80% for patients with node-negative disease (stage
I/II), in contrast to 45e50% for patients with node-positive
tumors (stage III).23 Adjuvant chemotherapy in patients
with stage III colon cancer clearly improves survival.24e26
The number of examined lymph nodes in a colectomy spec-
imen varies widely. This may be due to variations in the
surgical technique or the pathologist’s attempt in retrieving
the nodes from the resected specimen. There is substantial
evidence that the number of lymph nodes examined has an
important impact on survival in patients with colon can-
cer.4,7,9,27 An oncological specialized surgeon probably
performs a more extensive lymphadenectomy which yields
more nodes in the specimen. In addition, a pathologist who
performs a more precise examination of the specimen also
provides more accurate staging. It has not been possible toidentify a single mechanism for improved outcome with in-
creased node count. In our study the type of resection and
the fixation technique are significant factors in the number
of recovered lymph nodes. It is known that generally less
lymph nodes are found in a sigmoidectomy or transversec-
tomy specimen than in a right or left hemicolectomy spec-
imen. Regarding the fixation technique, comparisons of
mDF with previously described methods are clearly in fa-
vor of mDF. It is neither time-consuming nor costly and
does not involve the use of noxious substances like diethyl
ether or xylene which are used in fat clearance techniques.
(http://members.aol.com/RSRICHMOND/histology.html).
In addition, mDF can be used with conventional ventilation
devices. After 24e48 h of fixation specimens can be pro-
cessed or transferred to alcohol or formalin for storage.
Due to this rapid effect, safety and low costs it is ideal for
use in a busy primary or tertiary care hospital. With mDF
lymph nodes turn white in the yellow mesenteric fat, mak-
ing it easier for the pathologist to identify even small lymph
nodes, thereby reducing the operator dependence in lymph
node retrieval.21 Two studies showed that 72% of the met-
astatic lymph nodes are smaller than 5 mm in diameter.5,6
In our study indeed more and smaller lymph nodes are
found with mDF, which may lead to an increase in lymph
node metastases.N-stageNot only found more lymph nodes were detected after
the introduction of mDF, but we also found more and
smaller positive nodes. This can be explained by the white
color of regional nodes, which facilitates detection com-
pared to conventional manual dissection with non-white no-
des. In addition, more micrometastases were noted with
mDF. Both factors probably contributed to 11% more
node-positive patients after the introduction of this mDF.
Although not significant with p¼ 0.077, it does seem clin-
ically relevant for nodal staging. It could be that our popu-
lation is just too small to detect a significant difference.
Therefore, larger studies are required to demonstrate the
real impact of additional, smaller lymph nodes on prognosis
and/or their therapeutic significance. It was not possible to
find a cutoff value in the number of lymph nodes to be exam-
ined to find more nodal metastases with this modified fixa-
tion method. Using the recommended cutoff number of 12
nodes we did not find a significant difference in the percent-
age of node-positive patients.1,14 Even when we used cutoff
points of 6, 14 or 18 lymph nodes as mentioned in most stud-
ies,8,15,28 no significant difference in node-positivity was
found. Again, insufficient patient numbers might play
a role. As Goldstein stressed the importance to examine
even lymph nodes of 1 or 2 mm in diameter4 our study con-
firmed that the difference in N-stage seems to depends on the
smaller metastases found after mDF fixation. Therefore, it is
important to search also for smaller nodes and not only for
the highest number of large nodes.5
529W. Kelder et al. / EJSO 34 (2008) 525e530In this single center study the number of nodes recovered,
the surgeons involved in the operation and the pathologists
were of no significant importance. The only important factors
were T-stage and the use of mDF. The increase in node-
positivity with higher T-stages is expected, as it represents
a more advanced disease.Effects of staging on adjuvant therapyAs the two patient groups are not related, we cannot
state that there is any upstaging after mDF. We have
only observed that with mDF 41% of the patients had
lymph node metastases compared to 30% with formalin
fixation. We have to wait for the survival data of both pa-
tient groups before we can draw any conclusions on the
importance of this fixation technique for staging and prog-
nosis. Hypothetically, it is interesting to calculate what
could happen if 11% more patients would be offered ad-
juvant chemotherapy, keeping in mind that before July
2004 patients with less than 12 examined lymph node
did not automatically receive chemotherapy in our region.
In our hospital, we treat a part of the population covered
by the Comprehensive Cancer Center North Netherlands
(CCCNN). In this northern region, 625 colon resections
are performed annually in colon cancer patients without
proven metastases. An increase of 11% in lymph node
metastases will lead to 69 more patients being referred
for adjuvant chemotherapy. With the current chemother-
apy regimens an increase in the 5-year survival rate of
15e20% can be expected compared to no adjuvant ther-
apy at all.29 Considering this, about 10e14 people would
benefit in overall survival, assuming that they all do re-
ceive adjuvant treatment.
Conclusion
After adequate surgical resection in patients with colon
cancer, the pathologists may improve the staging procedure
by using the mDF fixation technique which is simple, rapid
and cheap. With this method more and smaller lymph nodes
and smaller nodal metastases were detected. This may
result in upstaging and a possible survival benefit as more
patients will be offered adjuvant chemotherapy.
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